Take Q2 FY27 Share Price & Earnings Call Analysis

₹12.62-1.71% today
Market cap
₹187 Cr
P/E
21.37
ROE
16.54%
PEG
0.80
Price to sales
1.64
Debt to equity
0.00
52W high / low
₹50.1 / ₹10.1
Sales growth (5Y)
-41.25%
EBITDA margin
0.29%
Net profit margin
7.86%
Sales (last year)
₹114 Cr

Incorporated in 2000, TAKE Solutions Ltd is in the business of Life Sciences and Support Services[1]

Potential multibaggers · Q2 FY27

Potential multibaggers in Healthcare Services
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. IndegeneGood growth
    3

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Take latest results (Sep 2026)

Revenue

₹29 Cr

Net profit

₹2 Cr

-65% YoY

Operating margin

6.02%

EPS

₹0.15

What management said on the call →

Take shareholding (Sep 2026)

Promoters

0.00%

unchanged QoQ

FIIs

0.21%

+0.01 pp QoQ

DIIs

0.00%

unchanged QoQ

Public

99.79%

−0.01 pp QoQ

Peers

Healthcare Services companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 2%+₹870 Cr—
240%+Flat₹576 Cr21.9
3Indegene20–40%Up 2%+₹16,058 Cr37.7
420–40%Up 2%+₹1,716 Cr17.0
520–40%Up 2%+₹622 Cr20.9
620–40%Flat₹1.23L Cr54.1

Financials of Take

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Shareholder Pattern

Take

Shareholding breakup across reporting periods.

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters +53.41%53.41%53.41%53.41%53.41%53.41%53.34%5.19%0.00%0.00%0.00%0.00%
FIIs +0.00%0.02%0.00%0.00%0.00%0.00%0.00%0.00%0.56%0.28%0.20%0.21%
DIIs +0.00%0.00%0.00%0.00%0.00%0.01%0.00%0.00%0.00%0.00%0.00%0.00%
Public +46.59%46.56%46.58%46.58%46.59%46.58%46.65%94.81%99.44%99.73%99.80%99.79%
No. of Shareholders79,33681,93880,28878,03377,16375,98875,14174,41070,32464,69963,21363,302

Financials of Take

Quarterly Results

Quarter-by-quarter operating performance

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales +0.050.000.000.000.000.000.000.000.000.0054.1930.3729.42
YoY Sales growth-99.88%-100.00%-100.00%-100.00%-100.00%
Expenses +1.501.9815.762.220.902.891.150.440.300.3555.0130.6427.65
Operating Profit-1.45-1.98-15.76-2.22-0.90-2.89-1.15-0.44-0.30-0.35-0.82-0.271.77
OPM %-2,900.00%-1.51%-0.89%6.02%
Other Income +0.414.07-93.70-0.97-0.2351.31-3.48-0.296.921.465.181.330.44
Interest0.560.540.540.490.500.730.240.180.170.000.000.000.00
Depreciation0.300.110.010.010.010.010.010.000.000.000.000.000.00
Profit before tax-1.901.44-110.01-3.69-1.6447.68-4.88-0.916.451.114.361.062.21
Tax %-18.42%248.61%0.55%1.63%-3.66%0.00%0.00%0.00%2.48%0.00%0.00%0.00%0.00%
Net Profit +-1.55-2.14-110.61-3.75-1.5847.68-4.88-0.916.291.114.361.062.21
EPS in Rs-0.10-0.14-7.48-0.25-0.113.22-0.33-0.060.430.080.290.070.15

Financials of Take

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales +7301,0301,3451,5872,0392,2137746551894054114
Sales growth-10%+41%+31%+18%+28%+9%-65%-15%-71%-98%-100%
Expenses +5818171,0821,2811,6552,04484764820824756114
Operating Profit149213262307384169-737-19-20-7-20
OPM %20%21%20%19%19%8%-9%1.1%-10%-569%-3.5%0.3%
Other Income +8211361126-211-677-56-9247138
Interest131523212541372972200
Depreciation60748710415416711580171000
Profit before tax85145165188216-13-437-779-99-11637119
Tax %6%14%11%15%17%-15%3%0%2%3%0%1%
Net Profit +80125146160178-11-450-782-100-12037119
EPS in Rs5.719.7810.7410.8511.99-0.84-30.56-52.88-6.78-8.092.530.730.59
Dividend Payout %17%10%9%15%8%0%0%0%0%0%0%0%

Financials of Take

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital12121315151515151515151515
Reserves5126198981,3141,5041,5611,11016694-2461619
Borrowings +209336237323474553514594637000
Other Liabilities +18924622118933933618798469601656
Total Liabilities9221,2141,3691,8402,3312,4651,8261,22322488363640
Fixed Assets +3595435545891,0911,2349341017330000
CWIP173214241103110000
Investments621105910187000000
Other Assets +5416477851,1501,1881,2138851,11914058363640
Total Assets9221,2141,3691,8402,3312,4651,8261,22322488363640

Financials of Take

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +741515612110421113530209-16-4
Cash from Investing Activity +-14-292-130-179-474-233-5715-3-7222
Cash from Financing Activity +-111115630210021-84-55-36-12-3-1
Net Cash Flow49-30-18243-270-2-6-10-18-103-3
Free Cash Flow4635-3039-2354133-2-122-16-4
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit52%76%26%44%30%156%-212%704%-114%-43%217%208%

Financials of Take

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days1201071181089411620545587151
Inventory Days0
Days Payable
Cash Conversion Cycle1201071181089411620545587151
Working Capital Days42199085678014028-42-5,559123
ROCE %13%16%17%15%13%1%-9%-6%-14%-22%11%19%

Take: frequently asked questions

What is Take share price today?

Take last traded at ₹12.62, with a market capitalisation of ₹187 Cr and a P/E ratio of 21.4.

What were Take's latest quarterly results?

For the quarter ended Sep 2026, Take reported revenue of ₹29 Cr and net profit of ₹2 Cr, with an operating margin of 6.02%.

Is Take's profit growing?

Net profit was ₹2 Cr in Sep 2026 against ₹6 Cr in Sep 2025, a change of -65%.

What is Take's EPS?

Take's earnings per share for the quarter ended Sep 2026 was ₹0.15.

What is the promoter holding in Take?

Promoters held 0.00% of Take in Sep 2026 (unchanged versus Jun 2026).

How much do FIIs and DIIs hold in Take?

In Sep 2026, foreign institutional investors held 0.21% and domestic institutions (including mutual funds) held 0.00% of Take.

What is Take's ROE and ROCE?

Take's return on equity is 16.5% and its return on capital employed is 18.5%.

Does Take pay a dividend?

Take's dividend yield is 0% at the current price; see the Take dividends page for past payouts.

Which sector does Take belong to?

Take is in the Healthcare Services sector. Its peer comparison and sector ranking are on this page.

What did Take's management say on the latest earnings call?

Arthneeti's analysis of the Q2 FY27 earnings call covers revenue, margins, capex and fundraising guidance from Take's management.

How does Arthneeti AI analyse Take?

Arthneeti reads Take's earnings call transcripts and filings and scores revenue growth, margins, capex and fundraising, then ranks the company against its sector.

Others in Healthcare Services this season

  • Chandan Healthca (Q2 FY27)

    Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor

  • Invicta Diagnostic (Q2 FY27)

    Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2

  • Unihealth Hosp (Q2 FY27)

    1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r

  • Sangani Hospital (Q2 FY27)

    1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.